PHARMACOKINETICS OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM-IV (CHIP) IN PATIENTS WITH ADVANCED CANCER

被引：1
|
作者：
PENDYALA, L
GRECO, W
COWENS, JW
MADAJEWICZ, S
CREAVEN, PJ
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CTR COMP,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 28
页数：6
相关论文
共 28 条
  • [1] CLINICAL-TRIAL OF IPROPLATIN (CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM-IV, CHIP) IN PATIENTS WITH ADVANCED BREAST-CANCER
    CASPER, ES
    SMART, TC
    HAKES, TB
    OCHOA, M
    KAUFMAN, RJ
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (02) : 87 - 91
  • [2] CLINICAL PHARMACOKINETICS OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM-IV (CHIP) - A NEW PLATINUM DRUG IN PHASE-I TRIAL
    PENDYALA, L
    COWENS, JW
    MITTELMAN, A
    CREAVEN, PJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 127 - 127
  • [3] STUDIES ON THE PHARMACOKINETICS AND METABOLISM OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM(IV) IN THE DOG
    PENDYALA, L
    COWENS, JW
    CREAVEN, PJ
    CANCER TREATMENT REPORTS, 1982, 66 (03): : 509 - 516
  • [4] PHASE-I STUDY OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS (ISOPROPYLAMINE)-PLATINUM-IV (CHIP)
    RIBAUD, P
    GOUVEIA, J
    MISSET, JL
    MATHE, G
    ANTICANCER RESEARCH, 1985, 5 (06) : 583 - 583
  • [5] PHASE-I CLINICAL-EVALUATION OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM-IV (CHIP, JM-9)
    YAP, BS
    TENNEY, DM
    YAP, HY
    PLAGER, C
    PAPADOPOLOUS, NE
    LEE, FH
    ISSELL, BF
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 166 - 166
  • [6] PHASE-I CLINICAL-TRIAL OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM(IV) (CHIP)
    CREAVEN, PJ
    MADAJEWICZ, S
    PENDYALA, L
    MITTELMAN, A
    PONTES, E
    SPAULDING, M
    ARBUCK, S
    SOLOMON, J
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 795 - 800
  • [7] PRE-CLINICAL STUDIES OF DIHYDROXY-CIS-DICHLORO-BIS-ISOPROPYLAMINE PLATINUM-IV (CHIP)
    MIHICH, E
    BULLARD, G
    PAVELIC, Z
    CREAVEN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 426 - 426
  • [8] PHARMACOKINETICS OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPYLAMINE PLATINUM IV (IPROPLATINUM, CHIP) IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION AND FOLLOWING INTRAPERITONEAL ADMINISTRATION
    KERR, DJ
    HARDING, M
    FARMER, JG
    AMARIN, J
    BLACKIE, RG
    HARLAND, SJ
    KAYE, SB
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1988, 5 (03): : 153 - 158
  • [9] PHASE-I STUDY OF CIS-DICHLORO-TRANS-DIHYDROXY-BIS-ISOPROPHYLAMINE PLATINUM-IV (CHIP)
    BRAMWELL, V
    ANDERSON, H
    THATCHER, N
    HOWELL, A
    OMALLEY, S
    CROWTHER, D
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 103 - 103
  • [10] CELL-CYCLE PHASE SENSITIVITY TO CIS-DICHLORO-BIS (ISOPROPYLAMINE) TRANS-DIHYDROXY PLATINUM (IV) (CHIP)
    EDWARDS, PG
    NIAS, AHW
    CELL AND TISSUE KINETICS, 1986, 19 (04): : 419 - 427
123